Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 725-733

  Jeyarajan, Sivakumar ^a   Xavier, Jennifer ^a   Rao, N Madhusudhana ^a   Gopal, Vijaya ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Cell targeting; HER2 receptors; Heregulin; Nuclear localization sequences; Nucleic acid delivery; Transfection

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITOPE; HEREGULIN ALPHA; HEREGULIN ALPHA1; HYBRID PROTEIN; ISOPROTEIN; NEU DIFFERENTIATION FACTOR; PLASMID DNA; POLYHISTIDINE TAG; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ENHANCED GREEN FLUORESCENT PROTEIN; ERBB2 PROTEIN, HUMAN; GREEN FLUORESCENT PROTEIN; HER2 PROTEIN, HUMAN; PRIMER DNA;

AEROBIC FERMENTATION; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR LOCALIZATION SIGNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; TARGET CELL; AMINO ACID SEQUENCE; BREAST TUMOR; DRUG DELIVERY SYSTEM; FEMALE; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NANOMEDICINE; NUCLEOTIDE SEQUENCE; PLASMID; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; DRUG DELIVERY SYSTEMS; FEMALE; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; NANOMEDICINE; NUCLEAR LOCALIZATION SIGNALS; PLASMIDS; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 79952117885     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S13040     Document Type: Article

References (26)

1. Abes S, Moulton H, Turner J, et al. Peptide-based delivery of nucleic acids: Design, mechanism of uptake and applications to splice- correcting oligonucleotides. Biochem Soc Trans. 2007;35:53-55.
2. Lundberg P, El-Andaloussi S, Sutlu T, et al. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J. 2007;21:2664-2671.
3. Vives E. Present and future of cell-penetrating peptide mediated delivery systems: "Is the Trojan horse too wild to go only to Troy?" J Control Release. 2005;109:77-85.
4. Xavier J, Singh S, Dean DA, et al. Designed multi-domain protein as a carrier of nucleic acids into cells. J Control Release. 2009;133: 154-160.
5. Rajagopalan R, Xavier J, Rangaraj N, et al. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery. J Gene Med. 2007;9:275-286.
6. Fominaya J, Wels W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system. J Biol Chem. 1996;27:10560-10568.
7. Faltus T, Yuan J, Zimmer B, et al. Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neuoverexpressing breast cancer cells. Neoplasia. 2004;6:786-795.
8. Puri A, Kramer-Marek G, Campbell-Massa R, et al. HER2-specific affibody- conjugated thermosensitive liposomes (affisomes) for improved delivery of anticancer agents. J Liposome Res. 2008;18:293-307.
9. Tan M, Keng-Hsueh L, Yao J, et al. Selective inhibition of ErbB2-overexpressing breast cancer in vivo by novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide. Cancer Res. 2006;66:3764-3772.
10. Bidwell GL III, Davis AN, Raucher D. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides. J Control Release. 2009;135:2-10.
11. Holmes WE, Sliwkowski MX, Akita RW, et al. Identification of heregulin, a specific activator of p185erbB2. Science. 1992;256: 1205-1210.
12. Kern JA, Schwartz DA, Nordberg JE, et al. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res. 1990;50:5184-5187.
13. Medina-Kauwe LK, Maguire M, Kasahara N, et al. Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins. Gene Ther. 2001;8:1753-1761.
14. Canine BF, Wang Y, Hatefi A. Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells. J Control Release. 2009;138:188-196.
15. Arthanari Y, Pluen A, Rajendran R, et al. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting bcr-abl fusion gene in chronic myeloid leukemia cells. J Control Release. 2010;145:272-280.
16. Subramanian A, Ranganathan P, Diamond SL. Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells. Nat Biotechnol. 1999;17:873-877.
17. Gopal V, Prasad TK, Rao NM, et al. Synthesis and in vitro evaluation of glutamide-containing cationic lipids for gene delivery. Bioconjug Chem. 2006;17.6:1530-1536.
18. Zhang JS, Li S, Huang L. Cationic liposome-protamine-DNA complexes for gene delivery. Methods Enzymol. 2003;373:332-342.
19. Collins E, Birchall JC, Williams JM, Gumbleton M. Nuclear localisation and pDNA condensation in non-viral gene delivery. J Gene Med. 2007;9:265-274.
20. Medina-Kauwe LK, Kasahara N, Kedes L. 3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteins. Gene Ther. 2001;8:795-803.
21. Hyndman L, Lemoine JL, Huang L, Porteous JD, Boyd AC, Nan X. HIV-1 TAT protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J Control Release. 2004; 99:435-444.
22. Wu GY, Wu CH. Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro. Biochemistry. 1988;27:887-892.
23. Yu H, Chen X, Lu T, et al. Poly(L-lysine)-graft-chitosan copolymers: Synthesis, characterization, and gene transfection effect. Biomacromolecules. 2007;8:1425-1435.
24. Hill IR, Garnett MC, Bignotti F, Davis SS. In vitro cytotoxicity of poly(amidoamine)s: Relevance to DNA delivery. Biochim Biophys Acta. 1999;1427:161-174.
25. Szabo R, Mezo G, Pallinger E, et al. In vitro cytotoxicity, chemotactic effect, and cellular uptake of branched polypeptides with poly[L-lys] backbone by J774 murine macrophage cell line. Bioconjug Chem. 2008;19:1078-1086.
26. Escriou V, Carriere M, Scherman D, et al. NLS bioconjugates for targeting therapeutic genes to the nucleus. Adv Drug Deliv Rev. 2003;55:295-306.